TwinBeech Capital’s Charles River Laboratories CRL Stock Holding History

TwinBeech Capital’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24,274	Closed	-$3.8M	–	638
2025 Q3	$3.8M	Buy	+24,274	New	+$3.86M	0.15%	170
2025 Q2	–	Sell	-42,510	Closed	-$6.4M	–	700
2025 Q1	$6.4M	Sell	42,510 -1,970	-4%	-$330K	0.12%	213
2024 Q4	$8.21M	Buy	44,480 +41,840	+1,585%	+$8.06M	0.14%	171
2024 Q3	$520K	Buy	+2,640	New	+$549K	0.01%	589
2022 Q3	–	Sell	-27,954	Closed	-$5.98M	–	652
2022 Q2	$5.98M	Buy	+27,954	New	+$6.83M	0.27%	104
2022 Q1	–	Sell	-24,504	Closed	-$9.23M	–	534
2021 Q4	$9.23M	Buy	24,504 +13,706	+127%	+$5.32M	0.53%	49
2021 Q3	$4.46M	Buy	+10,798	New	+$4.48M	0.31%	92

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

TwinBeech Capital's CRL Position: Q4 2025 in Review

TwinBeech Capital sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 24,274 shares — an estimated $3.8M sold.

TwinBeech Capital first reported a position in CRL in Q3 2021 and held it in 7 quarters. The position peaked at $9.23M in Q4 2021. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

TwinBeech Capital reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
TwinBeech Capital sold 24,274 Charles River Laboratories shares in Q4 2025, an estimated $3.8M.
TwinBeech Capital first reported a position in Charles River Laboratories in Q3 2021 and held it in 7 quarters.
TwinBeech Capital's Charles River Laboratories position peaked at $9.23M in Q4 2021.
580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on TwinBeech Capital's 13F filing for Q4 2025, filed 17 Feb 2026.